Sensus Healthcare (SRTS) Stock Analysis & Winston Score

Sensus Healthcare is a small medical device company that makes machines used to treat skin conditions without surgery. Its main product is the SRT-100, a superficial radiation therapy (SRT) device that dermatologists and radiation oncologists use to treat non-melanoma skin cancers and keloid scars. The company sells primarily to outpatient clinics and dermatology practices in the United States. Sensus makes money by selling its SRT devices directly to medical practices and, increasingly, through service contracts and recurring revenue tied to those machines. The company operates mainly in the US, though it has pursued some international sales. Its gross margin is modest, and its operating losses reflect the high cost of running a small, specialized medical device business. The key growth driver is wider adoption of SRT as an alternative to surgery for skin cancer, but the main risk is its very small size and dependence on a narrow product line, which makes it vulnerable to competition and reimbursement policy changes.